Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis

Conditions

• Peritoneal Dialysis-associated Peritonitis
• Peritoneal Dialysis (PD)
• Pharmacokinetics
• Intravenous Administration
• Intravenous
• Meropenem
• Intraperitoneal
• Ampicillin
• Aztreonam
• Ciprofloxacin
• Minimum Inhibitory Concentration (MIC)

Interventions

• DRUG: Application of intraperitoneal and intravenous meropenem in in automated peritoneal dialysis patients without peritonitis
• DRUG: Application of intraperitoneal and intravenous ampicillin in automated peritoneal dialysis patients without peritonitis
• DRUG: Application of intraperitoneal and intravenous aztreonam in automated peritoneal dialysis patients without peritonitis
• DRUG: Application of intraperitoneal and intravenous ciprofloxacin in automated peritoneal dialysis patients without peritonitis

Sponsor

Karl Landsteiner Insitute for Nephrology and Haemato-Oncology

Collaborators

• [object Object]
• [object Object]
• [object Object]